Fonar Corp (FONR)
17.30
+0.99
(+6.07%)
USD |
NASDAQ |
May 06, 11:43
Fonar Cash from Investing (Quarterly): -0.133M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.133M |
| September 30, 2023 | -0.079M |
| June 30, 2023 | -0.6981M |
| March 31, 2023 | -2.204M |
| December 31, 2022 | -0.473M |
| September 30, 2022 | -0.963M |
| June 30, 2022 | -0.7663M |
| March 31, 2022 | -1.723M |
| December 31, 2021 | -1.481M |
| September 30, 2021 | -1.209M |
| June 30, 2021 | -0.6466M |
| March 31, 2021 | -1.94M |
| December 31, 2020 | -1.798M |
| September 30, 2020 | -0.435M |
| June 30, 2020 | -0.9606M |
| March 31, 2020 | 13.30M |
| December 31, 2019 | -2.349M |
| September 30, 2019 | -2.568M |
| June 30, 2019 | -0.4217M |
| March 31, 2019 | -15.87M |
| December 31, 2018 | -1.814M |
| September 30, 2018 | -0.469M |
| June 30, 2018 | -0.2761M |
| March 31, 2018 | -0.756M |
| December 31, 2017 | -1.218M |
| Date | Value |
|---|---|
| September 30, 2017 | -0.695M |
| June 30, 2017 | -2.423M |
| March 31, 2017 | -0.293M |
| December 31, 2016 | -0.961M |
| September 30, 2016 | -0.642M |
| June 30, 2016 | -4.450M |
| March 31, 2016 | -0.148M |
| December 31, 2015 | -0.387M |
| September 30, 2015 | -0.064M |
| June 30, 2015 | -0.0378M |
| March 31, 2015 | -0.111M |
| December 31, 2014 | -0.05M |
| September 30, 2014 | -0.072M |
| June 30, 2014 | -0.2879M |
| March 31, 2014 | -0.212M |
| December 31, 2013 | -0.106M |
| September 30, 2013 | -0.229M |
| June 30, 2013 | -20.42M |
| March 31, 2013 | -20.54M |
| December 31, 2012 | -0.091M |
| September 30, 2012 | -0.247M |
| June 30, 2012 | -0.5534M |
| March 31, 2012 | -0.219M |
| December 31, 2011 | -0.30M |
| September 30, 2011 | -0.155M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-2.568M
Minimum
Sep 2019
13.30M
Maximum
Mar 2020
-0.3973M
Average
-0.9606M
Median
Jun 2020
Cash from Investing (Quarterly) Benchmarks
| XWELL Inc | 6.822M |
| ProPhase Labs Inc | -1.264M |
| Applied DNA Sciences Inc | 0.00 |
| Veracyte Inc | -2.497M |
| OncoCyte Corp | 0.241M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 4.071M |
| Cash from Financing (Quarterly) | -2.406M |
| Free Cash Flow | 12.18M |
| Free Cash Flow Per Share (Quarterly) | 0.5998 |
| Free Cash Flow to Equity (Quarterly) | 3.95M |
| Free Cash Flow to Firm (Quarterly) | 3.946M |
| Free Cash Flow Yield | 10.61% |